Results 131 to 140 of about 919 (150)
Some of the next articles are maybe not open access.

Vulvovaginal Candidiasis Complicating Recurrent Bacterial Vaginosis

Sexually Transmitted Diseases, 1990
In this study the authors reveal a high incidence of asymptomatic and symptomatic vulvovaginal yeast infection in patients with recurrent bacterial vaginosis. Symptomatic yeast vaginitis in these patients presents frequently as a mixed infection with symptoms and signs of both clinical entities being present simultaneously.
V, Redondo-Lopez   +5 more
openaire   +2 more sources

Recurrent vulvovaginal candidiasis: A review of guideline recommendations

Australian and New Zealand Journal of Obstetrics and Gynaecology, 2017
BackgroundRecurrent vulvovaginal candidiasis (VVC) is a difficult‐to‐manage condition that affects 5–8% of women of reproductive age. Current treatment regimes have high relapse rates, resulting in poor quality of life for the women affected.AimTo compare the quality and content of current guidelines concerned with recurrent VVC and to develop a ...
Alexia, Matheson, Danielle, Mazza
openaire   +2 more sources

Management of recurrent vulvovaginal candidiasis: Unresolved issues

Current Infectious Disease Reports, 2006
The introduction and widespread use of long-term maintenance suppressive fluconazole prophylaxis for recurrent vulvovaginal candidiasis (RVVC) has improved the quality of life for thousands of women worldwide. Moreover, the regimen is no longer expensive, and it is safe and well tolerated. However, the regimen frequently fails to cure the condition and
openaire   +2 more sources

Not That Itch Again: Dealing With Recurrent Vulvovaginal Candidiasis

Nursing for Women's Health, 2008
Recurrent vulvovaginal candidiasis can be complicated for health professionals to diagnose and treat, and can be difficult for patients to cope with and manage. This article reviews the causes, risk factors, screening methods and mangement of this condition.
openaire   +2 more sources

Treatment of recurrent vulvovaginal candidiasis.

American family physician, 2000
Vulvovaginal candidiasis is considered recurrent when at least four specific episodes occur in one year or at least three episodes unrelated to antibiotic therapy occur within one year. Although greater than 50 percent of women more than 25 years of age develop vulvovaginal candidiasis at some time, fewer than 5 percent of these women experience ...
openaire   +1 more source

Oteseconazole: a long-awaited diversification of the antifungal arsenal to manage recurrent vulvovaginal candidiasis (RVVC)

Expert Review of Anti-Infective Therapy, 2023
Paul Vandecruys   +2 more
exaly  

Managing Recurrent Vulvovaginal Candidiasis

Journal of Women's Health
Sandhya, Nagarakanti   +2 more
openaire   +2 more sources

Oteseconazole (VIVOJA) for prevention of recurrent vulvovaginal candidiasis

Trends in Pharmacological Sciences, 2023
Giel Vanreppelen   +5 more
openaire   +2 more sources

Home - About - Disclaimer - Privacy